Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [2]
- Immunohistochemistry [3]
- Other assay [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-80956 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- PTPMT1 Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- This product is preservative free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%-0.1%).
- Concentration
- 1 mg/mL
Submitted references PAX2 promotes epithelial ovarian cancer progression involving fatty acid metabolic reprogramming.
Feng Y, Tang Y, Mao Y, Liu Y, Yao D, Yang L, Garson K, Vanderhyden BC, Wang Q
International journal of oncology 2020 Mar;56(3):697-708
International journal of oncology 2020 Mar;56(3):697-708
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of PTPMT1 in Lane A: 293T Whole Cell Lysate (60 µg). Samples were probed using a PTPMT1 Polyclonal Antibody (Product # PA5-80956) at a 1:500 dilution, followed by a Goat Anti-Rabbit IgG (H+L), Dylight 800 Secondary Antibody at a 1:10000 dilution. Western blot was performed under reducing conditions. Predicted band size:23 kDa. Observed band size:18 kDa.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western Blot using PTPMT1 Polyclonal Antibody (Product # PA5-80956) at 1:500 dilution. Lane A: 293T Whole Cell Lysate. Lysates/proteins at 60 μg per lane. Secondary Goat Anti-Rabbit IgG H&L (DyLight™ 800) at 1:10,000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 23 kDa. Observed band size: 18 kDa.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of human PTPMT1 in human liver with PTPMT1 Polyclonal Antibody (Product # PA5-80956, 1:1,000, formalin-fixed paraffin embedded sections).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of human PTPMT1 in human pancreas with PTPMT1 Polyclonal Antibody (Product # PA5-80956, 1:1,000, formalin-fixed paraffin embedded sections).
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of human PTPMT1 in human pancreatic carcinoma with PTPMT1 Polyclonal Antibody (Product # PA5-80956, 1:1,000, formalin-fixed paraffin embedded sections).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Figure 5 ACAA2 overexpression is associated with a poor prognosis of patients with ovarian cancer. (A and B) Kaplan-Meier progression-free survival curves for patients with a low or high expression of (A) ACAA2 or (B) PNLIP among the total number of patients; (C-E) Kaplan-Meier progression-free survival curves for patients with (C) a negative PAX2 expression (PAX2 - ) or positive PAX2 expression (PAX2 + ), (D) low or high ACAA2 expression or (E) low or high PNLIP in expression RAS positive (RAS + ) subgroup.
